16 July, 2019

Pharmaceutical companies, managers, healthcare professionals and researchers seek to strengthen the excellence of clinical trials in Spain

Farmaindustria brings together in Madrid more than 120 experts to continue advancing in an area in which our country is already an international benchmark Source: […]
24 June, 2019

The pharmaceutical industry facilitates the participation of more than 150,000 patients in clinical trials in the last 12 years

More than half of the clinical research with medicines is done in the early stages, the most complex Strengthen the participation of patients in all stages […]
17 June, 2019

Private healthcare already participates in half of clinical trials

Specifically, they collaborate in 48.5 percent of them according to Farmaindustria data Source: Between 2004 and 2018, private health centers have participated in 1,431 clinical […]
11 June, 2019

Spain takes a step forward in clinical research in early phases in pediatrics and rare diseases

Farmaindustria is working on a new online Guide for Early Phase Clinical Research Units for the benefit of the research community The University Hospital La Paz […]
30 May, 2019

CAR-T therapy, future option to improve the treatment of multiple myeloma

The day ‘Controversies in patients with myeloma: candidate or not to haematopoietic transplantation and in relapse’, organized by the Jiménez Díaz Foundation and the San Carlos […]
27 May, 2019

The resignation of May dilates the concern of the pharmaceutical companies before a Brexit without agreement

After almost three years at the head of the Government, Theresa May has announced that she will present her resignation on June 7. Source: This […]
24 May, 2019

Clinical trials, key to developing new drugs and valuable for the economy and cost savings health

Source: Each new drug that reaches patients has one behind or, in general, several successful clinical trials. The clinical trial, which in the vast majority […]
24 May, 2019

Savings of 10,000 euros / patient for the clinical trials of the industry

Source: The clinical trials promoted by the pharmaceutical industry “are not only vital to develop new treatments for patients, but also play an important role […]
24 May, 2019

Conference “University research and regulatory compliance of the RGPD”

Source: Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a […]
2 May, 2019

An atlas at the individual cell level will improve precision medicine in breast cancer

It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: Investigadores University of Zurich […]
29 April, 2019

The protection of intellectual property, key to the development of new medicines

Source: The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union […]
12 April, 2019

New agenda of the Aemps: management by objectives and supply plan

Source: The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to […]